Lars Fruergaard Jørgensen, Novo Nordisk CEO (Christopher Goodney/Bloomberg via Getty Images)

No­vo Nordisk to cut in­sulin prices by up to 75% in 2024

No­vo Nordisk is cut­ting the price of its in­sulin prod­ucts by up to 75%, the com­pa­ny an­nounced on Tues­day.

Be­gin­ning in Jan­u­ary 2024, No­vo Nordisk …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.